Citations (126)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (35)
Yan Shen Kee, Chee Kuan Wong, Muhammad Anis Abdul Aziz, Mohd Idzwan Zakaria, Fatimah Mohd Shaarif, Kee Seong Ng, Chong Kin Liam, Yong Kek Pang & Ee Ming Khoo. (2023) 30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2623-2631.
Read now
Read now
Petra Kristina Jacobson, Leili Lind & Hans Lennart Persson. (2023) The Exacerbation of Chronic Obstructive Pulmonary Disease: Which Symptom is Most Important to Monitor?. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1533-1541.
Read now
Read now
Juan José Soler-Cataluña, José Luis Izquierdo, Mónica Juárez Campo, Antoni Sicras-Mainar & Javier Nuevo. (2023) Impact of COPD Exacerbations and Burden of Disease in Spain: AVOIDEX Study. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1103-1114.
Read now
Read now
Charlotte Sandau, Ejvind Frausing Hansen, Thomas Jørgen Ringbæk, Thomas Kallemose, Dorthe Gaby Bove, Ingrid Poulsen, Vibeke Nørholm, Lars Pedersen, Jens Ulrik Stæhr Jensen & Charlotte Suppli Ulrik. (2023) Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 599-614.
Read now
Read now
Paul Jones, Osamu Hataji, Yoshimi Suzukamo, Bruce Crawford, Yoko Sakai, Takeo Ishii, Keiko Sato, Eri Sasaki, Kenichi Hashimoto & Toru Oga. (2023) Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan. COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 216-223.
Read now
Read now
Don Postel, Marceline Willekens, Saskia Werner, Nathan Hutting & Martin Keesenberg. (2023) The effects of reducing the frequency of long-term physiotherapy on patients with severe COPD: a Dutch multicenter study. European Journal of Physiotherapy 25:4, pages 187-192.
Read now
Read now
Francesco Patalano, Carolina Hache, Abhijit Pethe, Harneet Kaur, Nancy Kline Leidy, Tasneem Arsiwala, Nuzhat Afroz & Florian S Gutzwiller. (2022) Performance of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD: Evidence from Clinical and Online Patient Interaction Studies. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 3087-3096.
Read now
Read now
Marc Miravitlles, Fernando González-Torralba, Cristina Represas-Represas, Xavier Pomares, Eduardo Márquez-Martín, Cruz González, Carlos Amado, Carles Forné, Soledad Alonso, Bernardino Alcázar, Miriam Barrecheguren, Juan María Jurado Mirete & Elsa Naval. (2022) Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1577-1587.
Read now
Read now
Ingmar Bergs, Katja S Just, Annegret Müller, Julia C Stingl & Michael Dreher. (2022) Emergency Department Visits Due to Dyspnea: Association with Inhalation Therapy in COPD and Cases with Adverse Drug Reactions. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1827-1834.
Read now
Read now
Miguel Angel Martinez-Garcia & Marc Miravitlles. (2022) The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 621-630.
Read now
Read now
Sanjay Sethi, Barry J Make, Scott B Robinson, Shambhavi Kumar, Michael Pollack, Chad Moretz, Jill Dreyfus, Ann Xi, Dakota Powell & Norbert Feigler. (2022) Relationship of COPD Exacerbation Severity and Frequency on Risks for Future Events and Economic Burden in the Medicare Fee-For-Service Population. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 593-608.
Read now
Read now
Yanling Ding, Lina Sun, Ying Wang, Jing Zhang & Yahong Chen. (2022) Efficacy of ICS versus Non-ICS Combination Therapy in COPD: A Meta-Analysis of Randomised Controlled Trials. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 1051-1067.
Read now
Read now
Marc Miravitlles, Miguel Roman-Rodríguez, Xavier Ribera, John Ritz & José Luis Izquierdo. (2022) Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 245-258.
Read now
Read now
David Gillespie, Nick Francis, Haroon Ahmed, Kerenza Hood, Carl Llor, Patrick White, Emma Thomas-Jones, Helen Stanton, Bernadette Sewell, Rhiannon Phillips, Gurudutt Naik, Hasse Melbye, Rachel Lowe, Nigel Kirby, Ann Cochrane, Janine Bates, Mohammed Fasihul Alam & Christopher Butler. (2022) Associations with Post-Consultation Health-Status in Primary Care Managed Acute Exacerbation of COPD. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 383-394.
Read now
Read now
Yanping Du, Jun Lin, Xiaoxia Wang, Yan Zhang, Hua Ge, Ye Wang, Zhiyi Ma, Huaping Zhang, Jun Liu, Zhiyong Wang, Meixia Lin, Fayu Ni, Xi Li, Hui Tan & Shifan Tan. (2022) Early Pulmonary Rehabilitation in Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 69-80.
Read now
Read now
Ling Lin, Qing Song, Wei Cheng, Cong Liu, Yi-Yang Zhao, Jia-Xi Duan, Jing Li, Dan Liu, Xin Li, Yan Chen, Shan Cai & Ping Chen. (2022) Comparation of predictive value of CAT and change in CAT in the short term for future exacerbation of chronic obstructive pulmonary disease. Annals of Medicine 54:1, pages 875-885.
Read now
Read now
David Price, Rupert Jones, Pascal Pfister, Hui Cao, Victoria Carter, Anu Kemppinen, Björn Holzhauer, Alan Kaplan, Allan Clark, David M G Halpin, Hilary Pinnock, James D Chalmers, Job F M van Boven, Kai M Beeh, Konstantinos Kostikas, Nicolas Roche, Omar Usmani & Paul Mastoridis. (2021) Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes. Pragmatic and Observational Research 12, pages 25-35.
Read now
Read now
Haiyan Ge, Xuanqi Liu, Wenchao Gu, Xiumin Feng, Fengying Zhang, Fengfeng Han, Yechang Qian, Xiaoyan Jin, Beilan Gao, Li Yu, Hong Bao, Min Zhou, Shengqing Li, Zhijun Jie, Jian Wang, Zhihong Chen, Jingqing Hang, Jingxi Zhang & Huili Zhu. (2021) Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP. Journal of Inflammation Research 14, pages 3335-3348.
Read now
Read now
Wilhelmine H Meeraus, Bailey M DeBarmore, Hana Mullerova, William A Fahy & Victoria S Benson. (2021) Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3487-3502.
Read now
Read now
João Cardoso, António Jorge Ferreira, Miguel Guimarães, Ana Sofia Oliveira, Paula Simão & Maria Sucena. (2021) Treatable Traits in COPD – A Proposed Approach. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3167-3182.
Read now
Read now
Neil Patel, Kathryn Kinmond, Pauline Jones, Pamela Birks & Monica A Spiteri. (2021) Validation of COPDPredict™: Unique Combination of Remote Monitoring and Exacerbation Prediction to Support Preventative Management of COPD Exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1887-1899.
Read now
Read now
Ravi Kalhan, David Slade, Riju Ray, Chad Moretz, Guillaume Germain, François Laliberté, Qin Shen, Mei Sheng Duh, Sean Dale MacKnight & Beth Hahn. (2021) Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1149-1161.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Wilhelmine H Meeraus, Hana Mullerova, Céline El Baou, Marion Fahey, Edith M Hessel & William A Fahy. (2021) Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 225-244.
Read now
Read now
Sujith Ramachandran, Yiran Rong, Kaustuv Bhattacharya, Monika Salkar, Gerald McGwin, Yi Yang & John P. Bentley. (2021) Does Transient Opioid Use Increase Risk of Short-Term Respiratory Exacerbation among Older Adults with Chronic Obstructive Pulmonary Disease?. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 650-656.
Read now
Read now
Bruna Shara Vidal de Oliveira, Anna Claudia Sentanin, Leonardo Garbin Bueno, Marcela Maria Carvalho Da Silva, Juliano Ferreira Arcuri & Valéria Amorim Pires Di Lorenzo. (2021) Evaluation of the Level of Physical Activity and Muscle Strength of Quadriceps in Patients Hospitalized for E-COPD: A Longitudinal Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:5, pages 511-517.
Read now
Read now
Nuno Faria, Maria Inês Costa, Joana Gomes & Maria Sucena. (2021) Reduction of Severe Exacerbations of COPD during COVID-19 Pandemic in Portugal: A Protective Role of Face Masks?. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 226-230.
Read now
Read now
Alicia V Gayle, Jennifer K Quint & Elaine I Fuertes. (2021) Understanding the relationships between environmental factors and exacerbations of COPD. Expert Review of Respiratory Medicine 15:1, pages 39-50.
Read now
Read now
Hongna Dong, Yuqiu Hao, Dapeng Li, Zhenzhong Su, Wei Li, Bingqing Shi & Peng Gao. (2020) Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2249-2256.
Read now
Read now
Arschang Valipour, Pallav L Shah, Felix J Herth, Christophe Pison, Christian Schumann, Ralf-Harto Hübner, Peter I Bonta, Romain Kessler, Wolfgang Gesierich, Kaid Darwiche, Bernd Lamprecht, Thierry Perez, Dirk Skowasch, Gaetan Deslee, Armelle Marceau, Frank C Sciurba, Reinoud Gosens, Jorine E Hartman, Francesca Conway, Marina Duller, Martin Mayse, Holly S Norman & Dirk-Jan Slebos. (2020) Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2807-2816.
Read now
Read now
Arnaud Cavailles, Boris Melloni, Stéphane Motola, Florent Dayde, Marie Laurent, Katell Le Lay, Didier Caumette, Laura Luciani, Pierre Louis Lleu, Geoffrey Berthon & Thomas Flament. (2020) Identification of Patient Profiles with High Risk of Hospital Re-Admissions for Acute COPD Exacerbations (AECOPD) in France Using a Machine Learning Model. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 949-962.
Read now
Read now
Arora Sneh, Tiwari Pawan, Guleria Randeep, Mohan Anant, Kalaivani Mani, Vijay Hadda & Karan Madan. (2020) Acute Phase Proteins as Predictors of Survival in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Mechanical Ventilation. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:1, pages 22-28.
Read now
Read now
Lan Ai Kieu Le, Ane Johannessen, Jon Andrew Hardie, Odd Erik Johansen, Amund Gulsvik, Bjørn Egil Vikse & Per Bakke. (2019) Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1639-1655.
Read now
Read now
Massimiliano Polastri, Vittoria Comellini, Angela Maria Grazia Pacilli & Stefano Nava. (2018) Magnetic Stimulation Therapy in Patients with COPD: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 165-170.
Read now
Read now
Biaoxue Rong, Yufang Liu, Min Li, Tian Fu, Wenlong Gao & Hua Liu. (2018) Correlation of serum levels of HIF-1α and IL-19 with the disease progression of COPD: a retrospective study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3791-3803.
Read now
Read now
Articles from other publishers (91)
Nooshin Hemmati, Gholamreza Mortazavi Moghaddam, Fatemeh Salmani & Mahmood Zardast. (2023) Predictors of In-hospital Outcomes in Hospitalized Patients With COPD Exacerbation. Zahedan Journal of Research in Medical Sciences 25:2.
Crossref
Crossref
A. Calderón Montero. (2023) El eje cardiopulmonar y la mortalidad cardiovascular en el paciente EPOC. Medicina de Familia. SEMERGEN 49:4, pages 101928.
Crossref
Crossref
Stefanie N. Sveiven, Kyle Anesko, Joshua Morgan, Meera G. Nair & Tara M. Nordgren. (2023) Lipid-Sensing Receptor FFAR4 Modulates Pulmonary Epithelial Homeostasis following Immunogenic Exposures Independently of the FFAR4 Ligand Docosahexaenoic Acid (DHA). International Journal of Molecular Sciences 24:8, pages 7072.
Crossref
Crossref
Athanasios Voulgaris, Kostas Archontogeorgis, Stavros Anevlavis, Michail Fanaridis, Marios E. Froudarakis, Sofia Schiza & Paschalis Steiropoulos. (2023) Effect of compliance to continuous positive airway pressure on exacerbations, lung function and symptoms in patients with chronic obstructive pulmonary disease and obstructive sleep apnea (overlap syndrome). The Clinical Respiratory Journal 17:3, pages 165-175.
Crossref
Crossref
Thuonghien V. Tran, Gregory L. Kinney, Alejandro Comellas, Karin F. Hoth, Arianne K. Baldomero, A. James Mamary, Jeffrey L. Curtis, Nicola Hanania, Richard Casaburi, Kendra A. Young, Victor Kim, Barry Make, Emily S. Wan, Alejandro A. Diaz, John Hokanson, James D. Crapo, Edwin K. Silverman, Surya P. Bhatt, Elizabeth Regan, Spyridon Fortis, James D. Crapo, Edwin K. Silverman, Barry J. Make, Elizabeth A. Regan, Terri H. Beaty, Peter J. Castaldi, Michael H. Cho, Dawn L. DeMeo, Adel El Boueiz, Marilyn G. Foreman, Auyon Ghosh, Lystra P. Hayden, Craig P. Hersh, Jacqueline Hetmanski, Brian D. Hobbs, John E. Hokanson, Wonji Kim, Nan Laird, Christoph Lange, Sharon M. Lutz, Merry-Lynn McDonald, Dmitry Prokopenko, Matthew Moll, Jarrett Morrow, Dandi Qiao, Elizabeth A. Regan, Aabida Saferali, Phuwanat Sakornsakolpat, Edwin K. Silverman, Emily S. Wan, Jeong Yun, Juan Pablo Centeno, Jean-Paul Charbonnier, Harvey O. Coxson, Craig J. Galban, MeiLan K. Han, Eric A. Hoffman, Stephen Humphries, Francine L. Jacobson, Philip F. Judy, Ella A. Kazerooni, Alex Kluiber, David A. Lynch, Pietro Nardelli, John D. NewellJr.Jr., Aleena Notary, Andrea Oh, Elizabeth A. Regan, James C. Ross, Raul San Jose Estepar, Joyce Schroeder, Jered Sieren, Berend C. Stoel, Juerg Tschirren, Edwin Van Beek, Bram van Ginneken, Eva van Rikxoort, Gonzalo Vegas Sanchez Ferrero, Lucas Veitel, George R. Washko, Carla G. Wilson, Robert Jensen, Douglas Everett, Jim Crooks, Katherine Pratte, Matt Strand, Carla G. Wilson, John E. Hokanson, Erin Austin, Gregory Kinney, Sharon M. Lutz, Kendra A. Young, Surya P. Bhatt, Jessica Bon, Alejandro A. Diaz, MeiLan K. Han, Barry Make, Susan Murray, Elizabeth Regan, Xavier Soler, Carla G. Wilson, Russell P. Bowler, Katerina Kechris, Farnoush BanaeiKashani, Jeffrey L. Curtis, Perry G. Pernicano, Nicola Hanania, Mustafa Atik, Aladin Boriek, Kalpatha Guntupalli, Elizabeth Guy, Amit Parulekar, Dawn L. DeMeo, Craig Hersh, Francine L. Jacobson, George Washko, R. Graham Barr, John Austin, Belinda D'Souza, Byron Thomashow, Neil MacIntyreJr.Jr., H. Page McAdams, Lacey Washington, Charlene McEvoy, Joseph Tashjian, Robert Wise, Robert Brown, Nadia N. Hansel, Karen Horton, Allison Lambert, Nirupama Putcha, Richard Casaburi, Alessandra Adami, Matthew Budoff, Hans Fischer, Janos Porszasz, Harry Rossiter, William Stringer, Amir Sharafkhaneh, Charlie Lan, Christine Wendt, Brian Bell, Ken M. Kunisaki, Eric L. Flenaugh, Hirut Gebrekristos, Mario Ponce, Silanath Terpenning, Gloria Westney, Russell Bowler, David A. Lynch, Richard Rosiello, David Pace, Gerard Criner, David Ciccolella, Francis Cordova, Chandra Dass, Gilbert D'Alonzo, Parag Desai, Michael Jacobs, Steven Kelsen, Victor Kim, A. James Mamary, Nathaniel Marchetti, Aditi Satti, Kartik Shenoy, Robert M. Steiner, Alex Swift, Irene Swift, Maria Elena Vega-Sanchez, Mark Dransfield, William Bailey, Surya P. Bhatt, Anand Iyer, Hrudaya Nath, J. Michael Wells, Douglas Conrad, Xavier Soler, Andrew Yen, Alejandro P. Comellas, Karin F. Hoth, John NewellJr.Jr., Brad Thompson, MeiLan K. Han, Ella Kazerooni, Wassim Labaki, Craig Galban, Dharshan Vummidi, Joanne Billings, Abbie Begnaud, Tadashi Allen, Frank Sciurba, Jessica Bon, Divay Chandra, Joel Weissfeld, Antonio Anzueto, Sandra Adams, Diego Maselli-Caceres, Mario E. Ruiz & Harjinder Singh. (2023) Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. Respiratory Medicine 208, pages 107126.
Crossref
Crossref
Peter Alter, Tanja Lucke, Henrik Watz, Stefan Andreas, Kathrin Kahnert, Franziska C. Trudzinski, Tim Speicher, Sandra Söhler, Robert Bals, Benjamin Waschki, Tobias Welte, Klaus F. Rabe, Jørgen Vestbo, Emiel F. M. Wouters, Claus F. Vogelmeier & Rudolf A. Jörres. (2022) Cardiovascular predictors of mortality and exacerbations in patients with COPD. Scientific Reports 12:1.
Crossref
Crossref
Xiaomin Dang, Yongyong Kang, Xiaojian Wang, Wen Cao, Minhui Li, Ying He, Xinjie Pan, Kai Ye & Dan Xu. (2022) Frequent exacerbators of chronic obstructive pulmonary disease have distinguishable sputum microbiome signatures during clinical stability. Frontiers in Microbiology 13.
Crossref
Crossref
Pernille Heyckendorff Secher, Stine Hangaard, Thomas Kronborg, Lisa Korsbakke Emtekær Hæsum, Flemming Witt Udsen, Ole Hejlesen & Clara Bender. (2022) Clinical implementation of an algorithm for predicting exacerbations in patients with COPD in telemonitoring: a study protocol for a single-blinded randomized controlled trial. Trials 23:1.
Crossref
Crossref
Raúl H. Sansores, Paulina Paulin-Prado, Robinson Robles-Hernández, Francisco Montiel-Lopez, Nora Edith Bautista-Félix, Nicolás Eduardo Guzmán-Bouilloud, Ramcés Falfán-Valencia, Gloria Pérez-Rubio, Rafael de Jesús Hernández-Zenteno, Fernando Flores-Trujillo, Oliver Pérez-Bautista & Alejandra Ramírez-Venegas. (2022) Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure. Respiratory Medicine 204, pages 107010.
Crossref
Crossref
Kun Gao, Guangbo Qu, Cuihong Zhang, Huaibiao Li & Liang Sun. (2022) Effect of Influenza Vaccine on Prevention of Acute Attack of Chronic Airway Disease in Elderly Population. Vaccines 10:10, pages 1750.
Crossref
Crossref
Changhong Zhang, Jianhua Liu, Liang Cao, Gaixia Feng, Zhihua Zhang, Mengmeng Ji & Yaping Zhang. (2022) Deep Learning-Based Computed Tomography Features in Evaluating Early Screening and Risk Factors for Chronic Obstructive Pulmonary Disease. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
Crossref
Zichen Ji, José Javier Jareño-Esteban & Javier de Miguel-Díez. (2022) Role of Vaccines in COPD Patients. Open Respiratory Archives 4:3, pages 100191.
Crossref
Crossref
Fangbo Zhang, Feifei Guo, Yang Liu, Yi Zhang, Defeng Li & Hongjun Yang. (2022) Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1. Frontiers in Pharmacology 13.
Crossref
Crossref
Dennis Williams. (2020) The Role of the Pharmacist in Optimizing Outcomes With Roflumilast, a PDE4 Inhibitor for the Treatment of COPD. Journal of Pharmacy Practice 35:3, pages 445-454.
Crossref
Crossref
A. Machado, M. Barusso, J. De Brandt, K. Quadflieg, S. Haesevoets, M. Daenen, M. Thomeer, D. Ruttens, A. Marques & C. Burtin. (2022) Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review. Pulmonology.
Crossref
Crossref
Wade Michaelchuk, Ana Oliveira, Susan Marzolini, Mika Nonoyama, Aline Maybank, Roger Goldstein & Dina Brooks. (2022) Design and delivery of home-based telehealth pulmonary rehabilitation programs in COPD: A systematic review and meta-analysis. International Journal of Medical Informatics 162, pages 104754.
Crossref
Crossref
Mohit Bhutani, David B. Price, Tonya A. Winders, Heinrich Worth, Kevin Gruffydd-Jones, Ruth Tal-Singer, Jaime Correia-de-Sousa, Mark T. Dransfield, Rudi Peché, Daiana Stolz & John R. Hurst. (2022) Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective. Advances in Therapy 39:6, pages 2302-2322.
Crossref
Crossref
E. A. Orlova, I. P. Dorfman, A. R. Umerova, B. I. Kantemirova, M. A. Orlov & M. A. Abdullaev. (2022) ECONOMIC DAMAGE OF PNEUMOCOCCAL VACCINATION ABSENCE AS A RISK FACTOR FOR COMPLICATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Pharmacy & Pharmacology 10:2, pages 187-197.
Crossref
Crossref
Kang-Mo Gu, Sang-Won Yoon, Sun-Young Jung, Moon Seong Baek, Won Young Kim, Jae-Woo Jung, Jae-Chol Choi, Jong-Wook Shin, Jae-Yeol Kim, Byoung-Whui Choi & In-Won Park. (2022) Acute exacerbation of COPD increases the risk of hip fractures: a nested case-control study from the Korea National Health Insurance Service. The Korean Journal of Internal Medicine 37:3, pages 631-638.
Crossref
Crossref
Yu Fu, Emma J Chapman, Alison C Boland & Michael I Bennett. (2022) Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review. Palliative Medicine 36:5, pages 770-782.
Crossref
Crossref
Rutvij A. Khanolkar, Aleksandar Trajkovski, Arnav Agarwal, Merril A. Pauls & Eddy S. Lang. (2022) Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses. Internal and Emergency Medicine 17:3, pages 639-644.
Crossref
Crossref
Francis P Chmiel, Dan K Burns, John Brian Pickering, Alison Blythin, Thomas MA Wilkinson & Michael J Boniface. (2022) Prediction of Chronic Obstructive Pulmonary Disease Exacerbation Events by Using Patient Self-reported Data in a Digital Health App: Statistical Evaluation and Machine Learning Approach. JMIR Medical Informatics 10:3, pages e26499.
Crossref
Crossref
Jing Yang, Qiang Zhang, Jun Zhang, Yan Ouyang, Zepeng Sun, Xinlong Liu, Feng Qaio, Li-Qun Xu, Yunfei Niu & Jian Li. (2022) Exploring the Change of Host and Microorganism in Chronic Obstructive Pulmonary Disease Patients Based on Metagenomic and Metatranscriptomic Sequencing. Frontiers in Microbiology 13.
Crossref
Crossref
Emily R. Locke, Jessica P. Young, Catherine Battaglia, Tracy L. Simpson, Ranak Trivedi, Carol Simons, John C. Fortney, Paul Hebert, Erik R. Swenson, Jeffrey Edelman & Vincent S. Fan. (2022) Care-seeking and delay of care during COPD exacerbations. npj Primary Care Respiratory Medicine 32:1.
Crossref
Crossref
Holly Mitzel, Dakota Brown, Morgan Thomas, Byrne Curl, Mackenzie Wild, Andrea Kelsch, Judge Muskrat, Abulquasem Hossain, Ken Ryan, Olawale Babalola, Madison Burgard & Masfique Mehedi. (2022) Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina 58:2, pages 254.
Crossref
Crossref
Chew-Teng Kor, Yi-Rong Li, Pei-Ru Lin, Sheng-Hao Lin, Bing-Yen Wang & Ching-Hsiung Lin. (2022) Explainable Machine Learning Model for Predicting First-Time Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease. Journal of Personalized Medicine 12:2, pages 228.
Crossref
Crossref
Claire C. W. Zhong, Charlene H. L. Wong, William K. W. Cheung, Eng-kiong Yeoh, Chi Tim Hung, Benjamin H. K. Yip, Eliza L. Y. Wong, Samuel Y. S. Wong & Vincent C. H. Chung. (2022) Effectiveness of Peri-Discharge Complex Interventions for Reducing 30-Day Readmissions among COPD Patients: Overview of Systematic Reviews and Network Meta-Analysis. International Journal of Integrated Care 22:1, pages 7.
Crossref
Crossref
Amir Behnam Kharazmi, Atefeh Abedini, Arda Kiani, Shahriar Barouti & Shooka Mohammadi. (2022) Association of Serum Malondialdehyde and C-reactive Protein Levels with
Exacerbations of Chronic Obstructive Pulmonary Disease. Current Respiratory Medicine Reviews 18:1, pages 34-43.
Crossref
Crossref
Siyang Zeng, Mehrdad Arjomandi, Yao Tong, Zachary C Liao & Gang Luo. (2022) Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. Journal of Medical Internet Research 24:1, pages e28953.
Crossref
Crossref
Chih-Ru Lin, Karim Bahmed & Beata Kosmider. (2022) Dysregulated Cell Signaling in Pulmonary Emphysema. Frontiers in Medicine 8.
Crossref
Crossref
Raja Dhar, Deepak Talwar, Sundeep Salvi, B.V. Muralimohan, Sagar Panchal, Saiprasad Patil, Sagar Bhagat, Nishtha Khatri & Hanmant Barkate. (2022) Use of single-inhaler triple therapy in the management of obstructive airway disease: Indian medical experts’ review. ERJ Open Research 8:1, pages 00556-2021.
Crossref
Crossref
D. K. Arvind, T. Georgescu, C. A. Bates, D. Fischer & Q. Zhou. 2022. Body Area Networks. Smart IoT and Big Data for Intelligent Health Management. Body Area Networks. Smart IoT and Big Data for Intelligent Health Management
176
191
.
Xiaofeng Pu, Liang Liu, Bimin Feng, Zhengji Zhang & Guojun Wang. (2021) Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis. Respiratory Research 22:1.
Crossref
Crossref
Manuel B. Huber, Nelli Schneider, Florian Kirsch, Larissa Schwarzkopf, Anja Schramm & Reiner Leidl. (2021) Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life. Respiratory Research 22:1.
Crossref
Crossref
Svetlana I. Ovcharenko & Andrey S. Belevskiy. (2021) Benefit/risk ratio profile of single inhaler triple therapy for сhronic obstructive pulmonary disease patients. PULMONOLOGIYA 31:5, pages 645-652.
Crossref
Crossref
Fatma Tokgöz Akyıl, Seda Tural Önür, Hülya Abalı, Sinem Sökücü, Cengiz Özdemir, Neslihan Boyracı, Aslı Kocaoğlu & Sedat Altın. (2021) Hyponatremia is an independent predictor of emergency department revisits in acute exacerbation of COPD. The Clinical Respiratory Journal 15:10, pages 1063-1072.
Crossref
Crossref
Laura C. Myers, Rebecca Cash, Vincent X. Liu & Carlos A. CamargoJr.Jr.. (2021) Reducing Readmissions for Chronic Obstructive Pulmonary Disease in Response to the Hospital Readmissions Reduction Program. Annals of the American Thoracic Society 18:9, pages 1506-1513.
Crossref
Crossref
Özge İPEK DONGAZ, Dilara ÖZEN ORUK, Asalet Aybüke GÜP, Özge ORAL TAPAN, Banu BAYAR & Kılıçhan BAYAR. (2021) THE ATTACK PROFILE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RETROSPECTIVE STUDYKRONİK OBSTRÜKTİF AKCİĞER HASTALIĞINDA ATAK PROFİLİ: RETROSPEKTİF ÇALIŞMA. Karya Journal of Health Science 2:2, pages 44-48.
Crossref
Crossref
P. LuuS. Tulka, S. Knippschild, W. Windisch & M. Spielmanns. (2021) Risikoabschätzung einer akuten Exazerbation bei COPD-Patienten im Rahmen einer pneumologischen Anschluss-Rehabilitation anhand der Prävalenz und Schwergradausprägung von Komorbiditäten. Pneumologie 75:07, pages 516-525.
Crossref
Crossref
Asim Kichloo, Abdul Mannan Khan Minhas, Shakeel Jamal, Ali Tariq Shaikh, Micheal Albosta, Jagmeet Singh, Muhammad Zia Khan, Micheal Aljadah, Farah Wani, Muhammad Hisham Khan Wazir & Khalil Kanjwal. (2021) Trends and Inpatient Outcomes of Primary Heart Failure Hospitalizations with a Concurrent Diagnosis of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (from The National Inpatient Sample Database from 2004 to 2014). The American Journal of Cardiology 150, pages 69-76.
Crossref
Crossref
Constantin MUNTEANU, Gabriela DOGARU, Mariana ROTARIU & Gelu ONOSE. (2021) Therapeutic gases used in balneotherapy and rehabilitation medicine - scientific relevance in the last ten years (2011 – 2020) - Synthetic literature review. Balneo and PRM Research Journal:Vol.12, no.2, pages 111-122.
Crossref
Crossref
Elisabetta Zinellu, Angelo Zinellu, Alessandro G. Fois, Maria Carmina Pau, Valentina Scano, Barbara Piras, Ciriaco Carru & Pietro Pirina. (2021) Oxidative Stress Biomarkers in Chronic Obstructive Pulmonary Disease Exacerbations: A Systematic Review. Antioxidants 10:5, pages 710.
Crossref
Crossref
Abbas Rezaei, Atefeh Fakharian, Fariba Ghorbani, Esmaeil Idani, Atefeh Abedini & Hamidreza Jamaati. (2020) Comparison of high‐flow oxygenation with noninvasive ventilation in COPD exacerbation: A crossover clinical trial. The Clinical Respiratory Journal 15:4, pages 420-429.
Crossref
Crossref
Ioulianos Apessos, Athanasios Voulgaris, Michalis Agrafiotis, Dimitrios Andreadis & Paschalis Steiropoulos. (2021) Effect of periodontal therapy on COPD outcomes: a systematic review. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Donald P. Tashkin, Jill A. Ohar, Arkady Koltun, Richard Allan & Jonathan K. Ward. (2021) The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device. Pulmonary Medicine 2021, pages 1-7.
Crossref
Crossref
Wen Song, Yue Wang, Fengming Tian, Liang Ge, Xiaoqian Shang, Qiang Zeng, Ning Feng, Jiahui Fan, Jing Wang & Xiumin Ma. (2021) Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Disease Markers 2021, pages 1-9.
Crossref
Crossref
Paola Pierucci, Carla Santomasi, Nicolino Ambrosino, Andrea Portacci, Fabrizio Diaferia, Kjeld Hansen, Mikaela Odemyr, Steve Jones & Giovanna E. Carpagnano. (2021) Patient's treatment burden related to care coordination in the field of respiratory diseases. Breathe 17:1, pages 210006.
Crossref
Crossref
Wenjun Du, Weidong Zhang, Hongyu Hu, Miaoyun Zhang, Yiling He & Zhiming Li. (2021) Associations between ambient air pollution and hospitalizations for acute exacerbation of chronic obstructive pulmonary disease in Jinhua, 2019. Chemosphere 267, pages 128905.
Crossref
Crossref
Michael C. FerreraWassim W. LabakiMeiLan K. Han. (2021) Advances in Chronic Obstructive Pulmonary Disease. Annual Review of Medicine 72:1, pages 119-134.
Crossref
Crossref
Francesc Medina-Mirapeix, Roberto Bernabeu-Mora, Elisa Valera-Novella, Mariano Gacto-Sánchez, Myriam Bernabeu-Mora & María Piedad Sánchez-Martínez. (2021) The five-repetition sit-to-stand test is a predictive factor of severe exacerbations in COPD. Therapeutic Advances in Chronic Disease 12, pages 204062232098671.
Crossref
Crossref
V Amelia, T Siswantining & T Kamelia. (2021) Prediction model of exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD) at RSCM. Journal of Physics: Conference Series 1725:1, pages 012011.
Crossref
Crossref
John R. Hurst, Tonya Winders, Heinrich Worth, Mohit Bhutani, Kevin Gruffydd-Jones, Daiana Stolz & Mark T. Dransfield. (2020) A Patient Charter for Chronic Obstructive Pulmonary Disease. Advances in Therapy 38:1, pages 11-23.
Crossref
Crossref
Dirk-Jan Slebos, Bruno Degano, Arschang Valipour, Pallav L. Shah, Gaetan Deslée & Frank C. Sciurba. (2020) Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3). BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Ernesto Crisafulli, Alessandra Manco, Miquel Ferrer, Arturo Huerta, Claudio Micheletto, Domenico Girelli, Enrico Clini & Antoni Torres. (2020) Pneumonic versus Nonpneumonic Exacerbations of Chronic Obstructive Pulmonary Disease. Seminars in Respiratory and Critical Care Medicine 41:06, pages 817-829.
Crossref
Crossref
Alberto Papi, Sergey Avdeev, Peter M.A. Calverley, Carlos R. Cordeiro, Milos Jesenak, Vladimir Koblížek, Diana Petkova, Paola Rogliani, Hesham Tarraf, Nikolaos Tzanakis, Ruxandra Ulmeanu, Esra Uzaslan & Yochai Adir. (2020) Use of mucolytics in COPD: A Delphi consensus study. Respiratory Medicine 175, pages 106190.
Crossref
Crossref
Antonio Anzueto & Alan Kaplan. (2020) Dual bronchodilators in chronic obstructive pulmonary disease: Evidence from randomized controlled trials and real-world studies. Respiratory Medicine: X 2, pages 100016.
Crossref
Crossref
Marta Erdal, Ane Johannessen, Per Bakke, Amund Gulsvik, Tomas Mikal Eagan & Rune Nielsen. (2020) Incremental costs of COPD exacerbations in GOLD stage 2+ COPD in ever-smokers of a general population. Respiratory Medicine: X 2, pages 100014.
Crossref
Crossref
Biaoxue Rong, Tian Fu, Congxue Rong, Wen Liu, Kai Li & Hua Liu. (2020) Association between serum CCL-18 and IL-23 concentrations and disease progression of chronic obstructive pulmonary disease. Scientific Reports 10:1.
Crossref
Crossref
O. V. Zhukova & A. L. Khokhlov. (2020) Analysis of the long-term effectiveness of a drug in the treatment of a chronic disease is the basis of rational pharmacotherapy (on the example of the use of roflumilast in the treatment of chronic obstructive pulmonary disease). Kachestvennaya klinicheskaya praktika:3, pages 35-39.
Crossref
Crossref
Lili Jiang & Andrea S. Gershon. (2020) Using Health Administrative Data to Predict Chronic Obstructive Pulmonary Disease Exacerbations. Annals of the American Thoracic Society 17:9, pages 1056-1057.
Crossref
Crossref
Alexa Nuñez, Viviana Marras, Matevz Harlander, Evgeni Mekov, Matjaz Turel, Rossen Petkov, David Lestan, Nikolay Yanev, Silvia Negri, Miriam Barrecheguren, Pietro Pirina, Marc Miravitlles & Cristina Esquinas. (2020) Clinical and spirometric variables are better predictors of COPD exacerbations than routine blood biomarkers. Respiratory Medicine 171, pages 106091.
Crossref
Crossref
Zhenjiao Yang, Miaoling Cui, Xiaofang Zhang, Jing Bai, Lian Tang, Guirong Tan & Yun Jiang. (2020) Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Journal of Pain and Symptom Management 60:3, pages 559-567.
Crossref
Crossref
Elizabeth G. Bond, Lusine Abrahamyan, Mohammad K. A. Khan, Andrea Gershon, Murray Krahn, Ping Li, Rajibul Mian, Nicholas Mitsakakis, Mohsen Sadatsafavi, Teresa To & Petros Pechlivanoglou. (2020) Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study. PLOS ONE 15:8, pages e0236559.
Crossref
Crossref
Soo Kyung Park. (2020) Changes in symptoms and health-related quality of life in patients with exacerbated chronic obstructive pulmonary disease. Applied Nursing Research 54, pages 151278.
Crossref
Crossref
Lin-Yu Liao, Kuei-Min Chen & Hui-Fen Hsu. (2020) Cardiopulmonary Endurance of Hospitalized Older Adults With Chronic Obstructive Pulmonary Disease. Nursing Research 69:4, pages E27-E36.
Crossref
Crossref
Bart A.C. Noort, Kees Ahaus, Taco van der Vaart, Naomi Chambers & Rod Sheaff. (2020) How healthcare systems shape a purchaser’s strategies and actions when managing chronic care. Health Policy 124:6, pages 628-638.
Crossref
Crossref
Ka Wing To, Iris Fung‐Kam Lee, Kai Chow Choi, Yannes Tsz Yan Cheung & Doris Sau‐Fung Yu. (2020) An information‐motivation‐behavioural‐based model and adherence to inhalation therapy and other health outcomes in patients with chronic obstructive pulmonary disease: A pilot randomized controlled trial. International Journal of Nursing Practice 26:2.
Crossref
Crossref
Stanca‐Patricia Hogea, Emanuela Tudorache, Ariadna Petronela Fildan, Ovidiu Fira‐Mladinescu, Monica Marc & Cristian Oancea. (2020) Risk factors of chronic obstructive pulmonary disease exacerbations. The Clinical Respiratory Journal 14:3, pages 183-197.
Crossref
Crossref
Mieke R.C. Crutsen, Spencer J. Keene, Daisy J.A. Janssen Nienke Nakken, Miriam T. Groenen, Sander M.J. van Kuijk, Frits M.E. Franssen, Emiel F.M. Wouters & Martijn A. Spruit. (2020) Physical, Psychological, and Social Factors Associated with Exacerbation-Related Hospitalization in Patients with COPD. Journal of Clinical Medicine 9:3, pages 636.
Crossref
Crossref
Sara Fernández-García, Cristina Represas-Represas, Alberto Ruano-Raviña, Cecilia Mouronte-Roibás, Maribel Botana-Rial, Cristina Ramos-Hernández & Alberto Fernández-Villar. (2020) Social and clinical predictors of short- and long-term readmission after a severe exacerbation of copd. PLOS ONE 15:2, pages e0229257.
Crossref
Crossref
M.I. Smirnova, D.N. Antipushina & A.S. Kurekhyan. (2020) Chronic obstructive pulmonary disease and COVID-19: data by summer 2020, approaches to health care and prevention. Profilakticheskaya meditsina 123:8, pages 37.
Crossref
Crossref
Kaiser Jehan Peerzada. 2020. Chronic Lung Diseases. Chronic Lung Diseases
157
180
.
Florina Fiador, Matthieu Poyade & Louise Bennett. 2020. Biomedical Visualisation. Biomedical Visualisation
115
147
.
Christopher Parker-Rajewski, Anish Sethi & Rany T. Abdallah. 2020. Guide to the Inpatient Pain Consult. Guide to the Inpatient Pain Consult
145
165
.
Ulla Møller Weinreich. (2019) Domiciliary high-flow treatment in patients with COPD and chronic hypoxic failure: In whom can we reduce exacerbations and hospitalizations?. PLOS ONE 14:12, pages e0227221.
Crossref
Crossref
Kristina Vermeersch, Ann Belmans, Kris Bogaerts, Iwein Gyselinck, Nina Cardinaels, Maria Gabrovska, Joseph Aumann, Ingel K. Demedts, Jean-Louis Corhay, Eric Marchand, Hans Slabbynck, Christel Haenebalcke, Stefanie Vermeersch, Geert M. Verleden, Thierry Troosters, Vincent Ninane, Guy G. Brusselle & Wim Janssens. (2019) Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial. Respiratory Research 20:1.
Crossref
Crossref
Ari Jon Arason, Jon Petur Joelsson, Bryndis Valdimarsdottir, Snaevar Sigurdsson, Alexander Gudjonsson, Skarphedinn Halldorsson, Freyr Johannsson, Ottar Rolfsson, Fredrik Lehmann, Saevar Ingthorsson, Paulina Cherek, Gudmundur H. Gudmundsson, Fridrik R. Gardarsson, Clive P. Page, Olafur Baldursson, Thorarinn Gudjonsson & Jennifer A. Kricker. (2019) Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia. Respiratory Research 20:1.
Crossref
Crossref
Sriram Sridhar, Hao Liu, Tuyet-Hang Pham, Gautam Damera & Paul Newbold. (2019) Modulation of blood inflammatory markers by benralizumab in patients with eosinophilic airway diseases. Respiratory Research 20:1.
Crossref
Crossref
Yiran Rong, John P Bentley, Gerald McGwin, Yi Yang, Benjamin F Banahan, Sara L Noble, Terri Kirby & Sujith Ramachandran. (2019) Association Between Transient Opioid Use and Short-Term Respiratory Exacerbation Among Adults With Chronic Obstructive Pulmonary Disease: A Case-Crossover Study. American Journal of Epidemiology 188:11, pages 1970-1976.
Crossref
Crossref
Devi Nurwidhiyasari, Shanti Farida Rachmi, Agustin Indracahyani & Tuti Nuraini. (2019) Relationship between severity and quality of life in chronic obstructive pulmonary disease patients at hospitals’ outpatient units in Jakarta. Enfermería Clínica 29, pages 159-165.
Crossref
Crossref
Kasiemobi E. Pulliam & Timothy A. Pritts. (2019) Non-invasive Ventilatory Support in the Elderly. Current Geriatrics Reports 8:3, pages 153-159.
Crossref
Crossref
Yunus Çolak, Shoaib Afzal, Jacob L. Marott, Børge G. Nordestgaard, Jørgen Vestbo, Truls S. Ingebrigtsen & Peter Lange. (2019) Prognosis of COPD depends on severity of exacerbation history: A population-based analysis. Respiratory Medicine 155, pages 141-147.
Crossref
Crossref
Izabela Zakowska, Katarzyna Kosiek, Anna Kowalczyk, Jacek Grabowski & Maciek Godycki-Cwirko. (2019) Community determinants of COPD exacerbations in elderly patients in Poland: protocol for a retrospective Big Data observational cohort study. BMJ Open 9:6, pages e030524.
Crossref
Crossref
Marc Miravitlles. 2019. ERS Handbook Respiratory Medicine. ERS Handbook Respiratory Medicine
332
338
.
Eneida M. Harrison & Victor Kim. (2019) Long-acting maintenance pharmacotherapy in chronic obstructive pulmonary disease. Respiratory Medicine: X 1, pages 100009.
Crossref
Crossref
Jason Girkin, Steven Maltby, Aran Singanayagam, Nathan Bartlett & Patrick Mallia. 2019. Rhinovirus Infections. Rhinovirus Infections
195
238
.
Erminia Ridolo, Cristoforo Incorvaia, Irene Martignago, Laura Pessina, Fulvio Lauretani, Luciano Loperfido, Gian Galeazzo Riario-Sforza, Annalisa Broglia, Bruna L. Gritti & Lorenzo Panella. (2018) Low incidence of pneumonia in COPD patients treated with inhaled corticosteroids undergoing pulmonary rehabilitation. Clinical and Molecular Allergy 16:1.
Crossref
Crossref
Camilla Koch Ryrsø, Nina Skavlan Godtfredsen, Linette Marie Kofod, Marie Lavesen, Line Mogensen, Randi Tobberup, Ingeborg Farver-Vestergaard, Henriette Edemann Callesen, Britta Tendal, Peter Lange & Ulrik Winning Iepsen. (2018) Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis. BMC Pulmonary Medicine 18:1.
Crossref
Crossref
Shengmei Li, Huiying Ma, Lijun Gan, Xiuqing Ma, Shangjie Wu, Mangui Li, Chih-Hsin Tang & Hsiao-Chi Tsai. (2018) Cancer antigen-125 levels correlate with pleural effusions and COPD-related complications in people living at high altitude. Medicine 97:46, pages e12993.
Crossref
Crossref
Laura J. Spece, Eric M. Epler, Lucas M. Donovan, Matthew F. Griffith, Margaret P. Collins, Laura C. Feemster & David H. Au. (2018) Role of Comorbidities in Treatment and Outcomes after Chronic Obstructive Pulmonary Disease Exacerbations. Annals of the American Thoracic Society 15:9, pages 1033-1038.
Crossref
Crossref
Jayson O. Swanson, Verena Vogt, Leonie Sundmacher, Terje P. Hagen & Tron Anders Moger. (2018) Continuity of care and its effect on readmissions for COPD patients: A comparative study of Norway and Germany. Health Policy 122:7, pages 737-745.
Crossref
Crossref